Document Detail

Acute ventricular reduction with the acorn cardiac support device: effect on progressive left ventricular dysfunction and dilation in dogs with chronic heart failure.
MedLine Citation:
PMID:  11766829     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND AIM: Surgical resection of myocardium that acutely reduces left ventricular (LV) volume in patients with advanced heart failure (HF), the so-called "Batista Operation," remains controversial. We examined the effects of acute LV reduction with the Acorn Cardiac Support Device (CSD) in dogs with HF (LV ejection fraction < 30%). METHODS: HF was produced in 15 dogs by intracoronary microembolization. In nine dogs, intravenous dobutamine was administered to reduce LV end-diastolic dimension (LVEDD) by 10%-25%. While on dobutamine infusion, the CSD, a preformed knitted polyester device, was surgically placed around the ventricles, anchored to the arteriovenous (AV) groove, and tailored anteriorly to fit snugly over the ventricles. Dogs were then weaned off dobutamine. RESULTS: On average, the procedure reduced LVEDD by 7 +/- 1 mm (range 5-12 mm). Of the nine dogs, two died before completion of the study and seven survived for the entire period. Six dogs did not undergo device placement and served as controls. All were followed for 3 months prior to sacrifice. In controls, LV end-diastolic volume increased after 3 months (66 +/- 5 mL vs 77 +/- 6 mL; p = 0.007), while in CSD-treated dogs (n = 7), it decreased (80 +/- 5 mL vs 60 +/- 3 mL; p = 0.002). In controls, LV ejection fraction (EF) decreased after 3 months (27 +/- 1% vs 23 +/- 1%; p = 0.001) but was unchanged in CSD-treated dogs (25 +/- 1% vs 26 +/- 1%; p = 0.66). Compared to controls, CSD-treated dogs showed improved LV diastolic dysfunction and chamber sphericity, decreased wall stress, and no functional mitral regurgitation (MR). CONCLUSION: In dogs with advanced HF, acute LV reduction with the Acorn CSD prevents progressive global LV dilatation and ameliorates functional MR.
P A Chaudhry; P V Anagnostopouls; T Mishima; G Suzuki; H Nair; H Morita; V G Sharov; C Alferness; H N Sabbah
Related Documents :
17338999 - Diagnostic characteristics of combining phonocardiographic third heart sound and systol...
6507289 - Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow an...
1282619 - Effects of prolonged nisoldipine administration on the "hibernating" myocardium.
12388219 - Slow rate during af improves ventricular performance by reducing sensitivity to cycle l...
16949549 - Effect of diastolic pressure on mlc2v phosphorylation in the rat left ventricle.
25157159 - Highway proximity and black carbon from cookstoves as a risk factor for higher blood pr...
21083789 - Swallow induces a peristaltic wave of distension that marches in front of the peristalt...
9485149 - Doppler-derived acceleration rate of right ventricular early filling as a measurement o...
2137299 - Chronic inhibition of fatty acid oxidation: new model of diastolic dysfunction.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of cardiac surgery     Volume:  16     ISSN:  0886-0440     ISO Abbreviation:  J Card Surg     Publication Date:    2001 Mar-Apr
Date Detail:
Created Date:  2001-12-19     Completed Date:  2002-03-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8908809     Medline TA:  J Card Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  118-26     Citation Subset:  IM    
Department of Medicine, Henry Ford Heart and Vascular Institute Henry Ford Health System, Detroit, Michigan, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Chronic Disease
Coronary Angiography
Dilatation, Pathologic / prevention & control
Disease Progression
Echocardiography, Doppler
Heart Failure / physiopathology,  surgery*,  ultrasonography
Heart Ventricles / physiopathology,  surgery*,  ultrasonography
Heart-Assist Devices*
Severity of Illness Index
Stroke Volume
Treatment Outcome
Ventricular Dysfunction, Left / physiopathology,  prevention & control*,  ultrasonography
Ventricular Remodeling*
Grant Support

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Safety and feasibility of a cardiac support device.
Next Document:  Growth hormone treatment in dilated cardiomyopathy.